How a new federal rule change may make access to treatment for opioid use disorder easier

On April 27, the Department of Health and Human Services announced new regulatory changes for prescribing buprenorphine for opioid use disorder (OUD). We sat down with Brad Finegood, Public Health – Seattle & King County’s Strategic Advisor on Behavioral Health, to learn more about the new rule change and how it may impact treatment access in our community.

Read More

Overdose update: Recent increase in overdose deaths linked to fentanyl-laced pills and powders

Update October 3, 2019 – Public Health officials continue to be concerned about increases in fentanyl overdose deaths in King County, driven by fentanyl found in counterfeit pills and in powders. As we reported below, between mid-June and mid-September 2019, there have been 141 suspected and confirmed drug overdose deaths. Since September 26, 2019, there […]

Read More

A behind the scenes look at buprenorphine ‘treatment on demand’

The Heroin and Prescription Opiate Addiction Taskforce recently published a 2017 Year End Report alongside highlights of actions taken to address the growing opiate epidemic in our region. The highlights show that in the past year, 40 new access points for buprenorphine–one of the best treatments available for opiate use disorder–became available. Buprenorphine supports recovery and reduces the […]

Read More